Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotini ...
Parkinson Disease;Parkinsons Disease With Dementia